UBS analyst Jon Windham downgrades Republic Services (NYSE:RSG) from Buy to Neutral.
Piper Sandler Maintains Overweight on Aziyo Biologics, Raises Price Target to $10.5
Piper Sandler analyst Matt O'Brien maintains Aziyo Biologics (NASDAQ:AZYO) with a Overweight and raises the price target from $9 to $10.5.